Skip to search formSkip to main contentSkip to account menu

2-cyanomethylimidazo(4,5-b)pyridine

Known as: 2-cyanomethyl-IMPY 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Acute toxicity of two Alzheimer’s disease radiopharmaceuticals: FDDNP and IMPY
Alzheimer’s disease (AD) is a neurodegenerative disorder that results in memory deficits. The effect of AD is the leading cause… 
2008
2008
IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.
2004
2004
Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
This study evaluated (18)F-labeled IMPY [6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine] derivatives as agents for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)